Regeneron Pharmaceuticals

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

6 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities Just now (07:03 PM IST)

Sanofi Pays Regeneron $1 Billion Upfront to Deepen Drug Alliance and Reignite R&D

Sanofi has agreed to pay Regeneron $1 billion upfront in a broadened collaboration that could be worth as much as $8 billion, extending one of the biopharma sector’s most productive partnerships. The deal gives Sanofi access to four early-stage assets and comes alongside a legal settlement, underscoring both the commercial value of the alliance and the strategic urgency to refresh each company’s pipeline.

By RDU Global Wire6 min read

Macro Economy & Fiscal PolicyJust now (06:45 AM IST)

Cumulative FDI Surges to $843 Billion Amid Record Inflows in 2025-26

India's cumulative Foreign Direct Investment (FDI) has reached an unprecedented $843 billion from 2014 to 2026, with a record $94.53 billion inflow in the last fiscal year, according to Commerce and Industry Minister Piyush Goyal.

4 min readRead →

Society, Crime & Public Affairs8h ago

'Neagley' Review: A Lean, Jolly Good Comfort Watch That Lets Maria Sten Lead

Amazon Prime Video's new Reacher spin-off, Neagley, arrives as a brisk, self-contained crime thriller that keeps Alan Ritchson's Reacher at the edges while putting Maria Sten's Frances Neagley firmly at the center. Built around a personal mystery, a quirky investigative team and a suitably twisty conspiracy, the series aims less for reinvention than for dependable, high-velocity entertainment.

6 min readRead →

Markets, IPOs & WealthSept 26, 2026

Institutional Investors Boost Stakes in Nifty 500 Stocks, Driving Gains of Up to 40%

Foreign Institutional Investors (FIIs) and mutual funds have significantly increased their holdings in various Nifty 500 stocks during the June 2026 quarter, leading to remarkable share price gains of up to 41%. This trend reflects a growing confidence in the Indian market as institutional interest broadens across multiple sectors.

3 min readRead →

Markets, IPOs & WealthSept 26, 2026

GIFT Nifty Surges to Record Heights: Volume and Open Interest Soar

On September 24, 2026, GIFT Nifty achieved unprecedented trading volume and open interest, marking a significant milestone in India's financial landscape. This surge reflects the growing confidence in India's economy and the strategic positioning of the NSE IX platform since its launch.

4 min readRead →

Startups & Venture CapitalSept 26, 2026

Rio Health Secures $4.5 Million to Expand Quick Pharmacy Network

Rio Health, a pharmacy-focused quick commerce startup, has successfully raised $4.5 million in a pre-Series A funding round. The investment aims to enhance its operational capabilities and expand its reach across India, addressing the growing demand for accessible healthcare solutions.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Regeneron Pharmaceuticals:

Washington, D.C.(1)Sanofi(1)